INTRODUCTION

Diabetes is a global health problem with significant human, social, and economic impacts. More than 300 million people worldwide live with diabetes. Each year, approximately 7 million new patients develop diabetes. Sleep disturbances are common among individuals with diabetes. Patients with type 2 diabetes have been shown to have an increased prevalence of periodic breathing and time spent in rapid eye movement sleep. In addition, patients with diabetes are reported to have higher rates of insomnia, excessive daytime sleepiness and a higher incidence of restless leg syndrome. A majority of these patients may also have obstructive sleep apnea (OSA) [1]. OSA and diabetes mellitus share several risk factors, including advanced age and obesity [2]. Diabetes and OSA appear to be associated independent of the degree of adiposity [3-9]. Because both diabetes and OSA are associated with increased cardiovascular morbidity and mortality, it is possible that the presence of both conditions results in additive or even synergistic health risks [10]. To promote better management of type 2 diabetes, sleep disorders must be addressed in these patients. Identifying sleep disturbances in type 2 diabetics and treating them early may improve overall prognosis and quality of life.

The present study was carried out to identify the prevalence of sleep disturbances among patients with type 2 diabetes in a southeast Asian Indian population and to determine the predictors of sleep impairment in this population using a validated instrument, the Pittsburgh Sleep Quality Index (PSQI).

METHODS

Participants

The study was carried out at the Sri Ramachandra Medical Center, a tertiary-care teaching hospital in Chennai, South India. The study population was comprised of type 2 diabetes patients attending the Endocrine Outpatient Clinic. The total study sample included 120 patients; 96 had type 2 diabetes alone, and 24 had type 2 diabetes with co-existing hypertension. Patients who were diagnosed as having type 2 diabetes within the past year were excluded from the study, as were patients with other comorbidities like malignancy, renal disorders, lung diseases, liver diseases, thyroid disorders, and cardiac diseases. Smokers and alcoholics were also excluded from the study. Protocols and informed consent documents were approved by the Institutional Ethics Board in accordance with International and National Guidelines. All participants signed an informed consent form before inclusion in the study. The study period extended from September 2010 to February 2011.

Data collection

For each patient, we recorded data regarding age, gender, duration of diabetes, and use of medications. Height, weight, and waist circumference were measured in all participants; body mass index (BMI, kg/m²) was calculated as weight divided by height squared. A detailed physical examination was then performed. All vital signs were recorded. Fasting blood glucose (FBG), postprandial blood glucose (PPBG), and glycosylated hemoglobin (HbA1c) values were available for all the patients and were recorded from their case sheets. All the study patients were on anti-diabetic medications, either insulin or oral hypoglycemic agents or both.

Research tool

In all patients, quality of sleep was evaluated by administering the PSQI through an interview. The PSQI is a self-report questionnaire that assesses sleep quality and quantity over a monthlong period [11]. The questionnaire consists of 19 self-rated questions and 5 questions that should be answered by bedmates or roommates. The latter questions were used only for clinical information and were not used in the scoring. The 19 questions were categorized into 7 components, which are graded on a scale that ranges from 0 to 3. The PSQI components are as follows: subjective sleep quality (C1), sleep latency (C2), sleep duration (C3), habitual sleep efficiency (C4), sleep disturbances (C5), use of sleeping medication (C6), and daytime dysfunction (C7). The sum of scores for these 7 components yields one global PSQI score, which ranges from 0 to 21, where the highest score indicates the worst sleep quality. A global PSQI ≥5 has a diagnostic sensitivity of 89.6 and specificity of 86.5 in distinguishing "poor sleepers" (PSQI ≥5) from "good sleepers" (PSQI <5) [12]. The design of the PSQI is such that the items and the component scores represent standard areas of clinical focus in patients with reported sleep problems [13].

Statistical analysis

Statistical analysis was conducted with the SPSS version 17.1 (SPSS Inc., Chicago, IL, USA). Quantitative variables were expressed as mean±standard deviation, and qualitative variables were expressed as percentage values. The scatter plot diagram was used to find the correlation of various variables with the global PSQI score. The R² value was obtained from the scatter plot from which the P value was determined. Logistic regression analysis was then applied to explore relationships between PSQI and other variables like age, gender, BMI, duration of diabetes, HbA1c, and choice of medications. For comparison between the three groups, we used the Kruskal-Wallis test. All tests were two-tailed, and we set the level of significance at P values of less than 0.05.

RESULTS

One hundred twenty patients completed the PSQI questionnaire and were included in the study. The demographic characteristics of these patients are listed in Table 1. Our sample consisted of 55 females and 65 males. The mean age of the participants was 53.9 years (standard deviation [SD], 9.2 years), and the average BMI was 27.09 kg/m² (SD, 5.3 kg/m²). Fifty-one patients (43%) were overweight (BMI, 25 to 29.9 kg/m²), 28 (23%) were obese (BMI ≥30 kg/m²), and the remaining 41 (34%) had a BMI <25 kg/m².

The mean PSQI score of the study patients was 7.08 (SD, 3.89), and 69% (n=83) had a PSQI score ≥5, indicating poor quality of sleep. Individual components of PSQI are shown in Table 2. Of the seven components of PSQI, sleep latency was the most affected in our study population. Average sleep latency was 35.3 minutes (SD, 33.84), and the mean duration of sleep was 375.04 minutes (SD, 68.40). Global PSQI score did not differ significantly in hypertensive patients (7.04±3.17) compared to normotensive patients (7.17±4.09).

A significant correlation was found between the duration of diabetes and the global PSQI score (R²=0.181, P<0.05), indicating that the duration of diabetes had a strong influence on sleep in our study sample (Fig. 1). This correlation was independent of other variables like age, gender, BMI, HbA1c, or choice of medications, as shown in Table 3. Duration of diabetes also had weaker correlations with the individual components of the PSQI, of which subjective sleep quality correlated the most (R²=0.123); however, this correlation was not statistically significant. No significant correlation existed between HbA1c and global PSQI score. In contrast, there was a positive trend (R²=0.03) between the two factors in patients with uncontrolled diabetes (HbA1c ≥7%). Other variables like BMI, age, gender, and choice of medications did not correlate with global PSQI score.

Further analysis was done based on medications. Participants were divided into three groups: 1) patients who took only oral hypoglycemic agents (OHAs); 2) patients who took only insulin; and 3) patients who took both. Their respective PSQI scores were 6.43±3.63 (only OHAs), 8.00±4.19 (only insulin), and 8.43±4.08 (both OHAs & insulin). Although the first group (only OHAs) had a low overall PSQI score compared to the other two groups, there was no statistically significant difference among the three groups in terms of individual components (like subjective sleep quality, sleep latency) or global PSQI score (Table 4).

DISCUSSION

Our results suggest that there is a high prevalence of sleep dysfunction in patients with type 2 diabetes. In our study, a high proportion (69%) of type 2 diabetics had a PSQI score ≥5, which suggests reduced and disturbed sleep in these patients. Among the individual components of PSQI, sleep latency was the most affected, followed by sleep quality and duration. Duration of diabetes was the greatest predictor of sleep disturbances among our study sample, while age, gender, BMI, insulin or OHA use or HbA1c did not correlate with sleep dysfunction. Mean duration of sleep per day was 6 hours and 15 minutes, suggesting that a majority of type 2 diabetics suffer from sleep disturbances.

Sleep disturbances are more common among diabetics than they are in the general population. Almost 50% of these patients have sleep apnea [14]; among obese patients with type 2 diabetes, the prevalence of sleep apnea has been estimated at 86% [15]. Sleep disturbances and sleep loss are also implicated in insulin resistance, a precursor to type 2 diabetes. Individuals who sleep more than 8 hours per day or less than 7 hours per day are at a modestly increased risk of all-cause mortality, cardiovascular disease, and developing symptomatic diabetes [16].

Sleep apnea and sleep-disordered breathing contribute to metabolic derangements such as glucose intolerance and insulin resistance independent of obesity [3-9]; accumulating evidence suggests that they may be independent risk factors for hypertension and cardiovascular disease [17-19]. However, the relationship between sleep-disordered breathing (SDB) and diabetes is not clearly understood. A few studies have attempted to evaluate the cross-sectional relationship, but they have had mixed results. In their study, Reichmuth et al. [20] concluded that SDB contributes to weight gain and obesity; these changes lead to increased insulin resistance, which in turn increases the patient's risk of developing diabetes. In a clinic-based study, Vgontzas and colleagues [8] found that patients with sleep-disordered breathing had significantly higher fasting glucose and insulin levels compared with a group of weight-matched control participants. They also suggested that the glucose intolerance and insulin resistance associated with sleep-disordered breathing may be intermediate in the putative causal pathway to increased cardiovascular morbidity and mortality [21,22].

Stoohs et al. [5] reported that worsening insulin sensitivity and SDB in a group of 50 "healthy, normotensive individuals" was completely accounted for by their increased BMI. Another study [3] found a relationship between fasting insulin level and increasing apnea-hypopnea index (AHI) in patients with BMI of 29 or greater but not in those with lower BMI. In our study, BMI did not have a significant correlation with global PSQI score. However, our results showed a trend toward a positive association of BMI ≥25 kg/m² with global PSQI score (R²=0.02), indicating that BMI may affect sleep quality in overweight and obese type 2 diabetes patients. This finding is in accordance with the study by Vorona et al. [23], who found a similar relationship. Our analysis also suggested that the choice of medications does not have a significant influence on sleep quality in type 2 diabetes patients.

Interestingly in our study, duration of diabetes significantly correlated with global PSQI score. Patients with a longer duration of diabetes had poor sleep quality independent of other variables. The reason for this is unclear but could be due to multiple factors, including neuropathy and nocturia, which are more prevalent in long-term diabetics. We did not find a significant correlation between HbA1c and global PSQI score. However, in patients with uncontrolled diabetes (HbA1c ≥7%), a mild positive association existed between the two, indicating poor quality of sleep in these patients. The study by Nakajima et al. [24] supported our observations by reporting a short sleep duration in individuals with high HbA1c levels. Sleep deprivation in these patients may in turn worsen their diabetic state by 1) triggering the secretion of stress hormones and proinflammatory cytokines, leading to glucose intolerance and decreased insulin sensitivity [8]; 2) increasing sympathetic nervous system activity [25,26], which may impair glucose regulation via the lipolytic effects of adrenergic stimulation of visceral adipose tissue [27]; and 3) decreasing levels of the satiety hormone leptin and increasing the hunger hormone ghrelin, thereby increasing hunger and food intake [28]. Recent evidence also suggests that sleep durations of 6 hours or less or 9 hours or more are associated with increased prevalence of diabetes and impaired glucose tolerance (IGT) [29]. The experimental restriction of sleep to 4 hours per night for 6 nights produced IGT in healthy young adults [30].

A number of studies have shown that treatment of sleep disorders may help in attaining better glycemic control in type 2 diabetics. Continuous positive airway pressure (CPAP) therapy significantly improved insulin sensitivity in 40 patients with sleep apnea. This improvement was observed within 2 days of treatment and was sustained over 3 months [31]. Insulin responsiveness increased by 28% in patients with type 2 diabetes after 4 months of CPAP therapy [32]. In patients with type 2 diabetes, postprandial glucose levels were significantly reduced after approximately 3 months of CPAP therapy that had been initiated to treat sleep apnea. HbA1c levels were significantly reduced in patients with HbA1c >7% [33]. Continuous blood glucose monitoring of type 2 diabetes patients on CPAP therapy for an average of 41 days demonstrated lower and more stable nocturnal glucose levels [34].

Based on the current evidence, a strong association exists between sleep and glucose regulation. Our study identified a higher prevalence of sleep dysfunction in type 2 diabetics, and there was a strong association between duration of diabetes and the quality of sleep in these individuals. Sleep latency was the most affected symptom among these patients. Our study reiterated the importance of sleep evaluation in type 2 diabetes patients, as better sleep quality in these patients may improve the overall prognosis of the disease by significantly reducing cardiovascular risks. Furthermore, treatment of sleep apnea improves insulin sensitivity and could benefit the metabolic profiles of these patients.

Our study has several limitations. First, we did not have a healthy non-diabetic control group in our study to facilitate a direct comparison. Second, we did not have polysomnographic measures of sleep in this study, so it was not possible to detect sleep disorders like obstructive sleep apnea. Third, we could not exclude the possibility of confounding effects by unmeasured variables, such as a sedentary lifestyle or poor diet. Finally, we did not find a significant correlation of HbA1c or BMI with sleep quality, which can be attributed to the smaller sample size of our study.

In summary, our study suggested that southeast Asian Indian patients with type 2 diabetes had a higher prevalence of sleep dysfunction relative to the general population. Our analysis also indicated that the duration of diabetes was the greatest predictor of sleep disturbances in diabetic patients. Identifying sleep disturbances in this population and treating them early could reduce significant cardiovascular risk.

Acknowledgements

ACKNOWLDEGMENTS

This research was not supported by any specific grants from any funding agencies in the public, commercial or not-for-profit sector.

The authors would like to thank Ms. R. Kavitha, Mrs. Vijaya Rani, Mr. D. R. Nagendra Kumar, Mr. Gowri Shankar, and Ms. Hepsi Kirubha for their contributions to this study. We also thank all study participants and health workers who participated in the study for their excellent cooperation.

NOTES

There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

REFERENCES

• 1. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008;133:496-506. ArticlePubMed
• 2. Early release of selected estimates based on data from the January-June 2003 National Health Interview Survey. Centers for Disease Control and Prevention cited 2005 Jan 20. Available from: http://www.cdc.gov/nchs/about/major/nhis/released200312.htm.
• 3. Strohl KP, Novak RD, Singer W, Cahan C, Boehm KD, Denko CW, Hoffstem VS. Insulin levels, blood pressure and sleep apnea. Sleep 1994;17:614-618. ArticlePubMed
• 4. Grunstein RR, Stenlof K, Hedner J, Sjostrom L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord 1995;19:410-418. PubMed
• 5. Stoohs RA, Facchini F, Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 1996;154:170-174. ArticlePubMed
• 6. Strohl KP. Diabetes and sleep apnea. Sleep 1996;19:S225-S228. ArticlePubMed
• 7. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000;118:580-586. ArticlePubMed
• 8. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-1158. ArticlePubMedPDF
• 9. Elmasry A, Lindberg E, Berne C, Janson C, Gislason T, Awad Tageldin M, Boman G. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001;249:153-161. ArticlePubMed
• 10. Boyer S, Kapur V. Obstructive sleep apnea: its relevance in the care of diabetic patients. Clin Diabetes 2002;20:126-132.ArticlePDF
• 11. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213. ArticlePubMed
• 12. Fiorentini A, Valente R, Perciaccante A, Tubani L. Sleep's quality disorders in patients with hypertension and type 2 diabetes mellitus. Int J Cardiol 2007;114:E50-E52. ArticlePubMed
• 13. Aloba OO, Adewuya AO, Ola BA, Mapayi BM. Validity of the Pittsburgh Sleep Quality Index (PSQI) among Nigerian university students. Sleep Med 2007;8:266-270. ArticlePubMed
• 14. Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 2007;13:355-362. ArticlePubMed
• 15. Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, Wadden TA, Kelley D, Wing RR, Sunyer FX, Darcey V, Kuna ST. Sleep AHEAD Research Group. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009;32:1017-1019. ArticlePubMedPMCPDF
• 16. Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006;129:76-80. ArticlePubMed
• 17. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829-1836. ArticlePubMed
• 18. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-1384. ArticlePubMed
• 19. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25. ArticlePubMed
• 20. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005;172:1590-1595. ArticlePubMedPMC
• 21. Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health Nations Health 1964;54:11-23. ArticlePubMed
• 22. Wingard DL, Berkman LF, Brand RJ. A multivariate analysis of health-related practices: a nine-year mortality follow-up of the Alameda County Study. Am J Epidemiol 1982;116:765-775. ArticlePubMed
• 23. Vorona RD, Winn MP, Babineau TW, Eng BP, Feldman HR, Ware JC. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 2005;165:25-30. ArticlePubMed
• 24. Nakajima H, Kaneita Y, Yokoyama E, Harano S, Tamaki T, Ibuka E, Kaneko A, Takahashi I, Umeda T, Nakaji S, Ohida T. Association between sleep duration and hemoglobin A1c level. Sleep Med 2008;9:745-752. ArticlePubMed
• 25. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000;279:H234-H237. ArticlePubMed
• 26. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metab 1999;84:1979-1985. ArticlePubMed
• 27. Lonnqvist F, Thorne A, Large V, Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol 1997;17:1472-1480. ArticlePubMed
• 28. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004;141:846-850. ArticlePubMed
• 29. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998;53(Suppl 3):S25-S28.
• 30. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-1439. ArticlePubMed
• 31. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC, Ficker JH. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156-162. ArticlePubMed
• 32. Brooks B, Cistulli PA, Borkman M, Ross G, McGhee S, Grunstein RR, Sullivan CE, Yue DK. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994;79:1681-1685. ArticlePubMed
• 33. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005;165:447-452. ArticlePubMed
• 34. Dawson A, Abel SL, Loving RT, Dailey G, Shadan FF, Cronin JW, Kripke DF, Kline LE. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 2008;4:538-542. ArticlePubMedPMC

Fig. 1

Correlation of global Pittsburgh sleep quality index (PSQI) score with duration of diabetes.

Table 1

Participant characteristics

Data are presented as mean±standard deviation.

BMI, body mass index; HbA1c, glycosylated hemoglobin; PSQI, Pittsburgh sleep quality index; FBG, fasting blood glucose; PPBG, postprandial blood glucose.

Table 2

PSQI subcomponents distribution

Data are presented as mean±standard deviation.

PSQI, Pittsburgh sleep quality index.

Table 3

Results of regression analysis

R² (Cox & Snell's) for this regression model was 0.132.

B, regression coefficient; SE, standard error; Exp (B), odds ratio; CI, confidence interval; BMI, body mass index; HbA1c, glycosylated hemoglobin.

Table 4

Comparison of PSQI components based on medications

Data are presented as mean±standard deviation.

PSQI, Pittsburgh sleep quality index; OHAs, oral hypoglycemic agents.

Figure & Data

References

Citations

Citations to this article as recorded by  

• Sleep Pattern and Diabetes: Finding from a Cross-Sectional Study in Iraq
  Israa M. Salih, Harith Kh. Al-Qazaz
  Eurasian Journal of Family Medicine.2024; 13(1): 1.     CrossRef
• Frequency of sleep disorders among patients with type 2 diabetes and contributing factors
  Mobina Riahi, Mohammad Ahmadpanah, Ali Reza Soltanian, Shiva Borzouei
  International Journal of Africa Nursing Sciences.2024; 20: 100756.     CrossRef
• Sleep Quality Assessment and Its Predictors Among Saudi Adults with Type 1 and Type 2 Diabetes: A Cross-Sectional Study
  Abdulaziz A. Alhoqail, Khaled H. Aburisheh, Abdulrahman M. Alammar, Mohammed A. Bin Mugren, Abdulrahman M. Shadid, Ibrahim K. Aldakhil, Hamza M. K. Enabi, Faisal N. Alotaibi
  International Journal of Environmental Research and Public Health.2024; 21(11): 1437.     CrossRef
• Prevalence of sleep disturbance and its associated factors among diabetes type-2 patients in Saudi Arabia
  Faisal Saeed Al-Qahtani
  Frontiers in Public Health.2024;[Epub]     CrossRef
• Associations of sleep quality with the skeletal muscle strength in patients with type 2 diabetes with poor glycemic control
  Takanori Hayashi, Nobuhiro Wada, Tetsuya Kubota, Chie Koizumi, Yoshitaka Sakurai, Masakazu Aihara, Satoshi Usami, Toshimasa Yamauchi, Naoto Kubota
  Journal of Diabetes Investigation.2023; 14(6): 801.     CrossRef
• Relation between sleep quality and glycemic control among type 2 diabetic patients
  Asmaa Ali Elsayed Ali
  Frontiers of Nursing.2023; 10(1): 115.     CrossRef
• The effect of glycemic control on sleep quality in type 2 diabetes mellitus
  Zeynep KOÇ, Banu BÖYÜK, Seydahmet AKIN, Özcan KESKİN, Nazire ALADAĞ
  The European Research Journal.2023; 9(5): 1056.     CrossRef
• Sleep Quality Among People with Type 2 Diabetes Mellitus During COVID-19 Pandemic: Evidence from Qatar’s National Diabetes Center
  Yasamin Abdu, Sarah Naja, Mohamed Izham Mohamed Ibrahim, Mariam Abdou, Romaisa Ahmed, Salma Elhag, Ahmed Saleh, Mohamed Yassin, Iheb Bougmiza
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 2803.     CrossRef
• Sleep disorders and risk of dementia in patients with new‐onset type 2 diabetes: A nationwide population‐based cohort study
  Dallae Jin, Jae Woo Choi
  Journal of Diabetes.2021; 13(2): 101.     CrossRef
• Evaluation of the Prevalence of Sleep Disorder Among Patients with Type 2 Diabetes Mellitus Referring to Ghaem Hospital from 2016 to 2017
  Zahra M. Khorasani, Vahid R. Ravan, Sepideh Hejazi
  Current Diabetes Reviews.2021; 17(2): 214.     CrossRef
• The Relationship Between Sleep Quality and HbA1c of Patients with Type 2 Diabetes
  Elif YILDIRIM AYAZ, Berna DİNCER
  İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi.2021; (15): 446.     CrossRef
• Health-related quality of life and sleep quality among North Indian type 2 diabetes mellitus patients: evidence from a cross-sectional study
  Md Azharuddin, Prem Kapur, Mohammad Adil, Pinaki Ghosh, Manju Sharma
  Sleep Medicine.2020; 73: 93.     CrossRef
• The impact of sleep duration and sleep quality on glycaemic control in Asian population with type 2 diabetes mellitus: A systematic literature review and meta-analysis of observational studies
  Md Azharuddin, Prem Kapur, Mohammad Adil, Pinaki Ghosh, Manju Sharma
  Clinical Epidemiology and Global Health.2020; 8(3): 967.     CrossRef
• Association of sleep disturbance with risk of cardiovascular disease and all-cause mortality in patients with new-onset type 2 diabetes: data from the Korean NHIS-HEALS
  Young Choi, Jae Woo Choi
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis
  Anitra D M Koopman, Joline W Beulens, Tine Dijkstra, Frans Pouwer, Marijke A Bremmer, Annemieke van Straten, Femke Rutters
  The Journal of Clinical Endocrinology & Metabolism.2020; 105(3): 614.     CrossRef
• Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine
  Richa Tripathi, Anju Dhawan, Ravindra Rao, Ashwani Kumar Mishra, Raka Jain, Sanjeev Sinha
  Journal of Addiction Medicine.2020; 14(2): 132.     CrossRef

• Sleep Quality and Associated Factors Among Diabetes Mellitus Patients in a Follow-Up Clinic at the University of Gondar Comprehensive Specialized Hospital in Gondar, Northwest Ethiopia: A Cross-Sectional Study

  
  Tesfamichael Tadesse Birhanu, Mohamed Hassen Salih, Hailemichael Kindie Abate
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4859.     CrossRef
• The Frequency of Poor Sleep Quality in Patients With Diabetes Mellitus and Its Association With Glycemic Control
  Rabia Farooque, Fivzia Herekar, Sundus Iftikhar, Muhammad Junaid Patel
  Cureus.2020;[Epub]     CrossRef
• Prevalence and correlates of sleep disorders in Greek patients with type 2 diabetes: comparison of an urban and a semi-urban population
  Athanasia Papazafiropoulou, Maria Stamatelatou, Louisa Mpoumi, Elias Georgopoulos, Maria Dasenaki, Andreas Melidonis 
  Archives of Medical Science – Atherosclerotic Diseases.2020; 5(1): 198.     CrossRef
• Sleep Quality and Blood Lipid Composition Among Patients with Diabetes
  Ameneh Barikani, Maryam Javadi, Sima Rafiei
  International Journal of Endocrinology and Metabolism.2019;[Epub]     CrossRef
• The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis
  Shaun Wen Huey Lee, Khuen Yen Ng, Weng Khong Chin
  Sleep Medicine Reviews.2017; 31: 91.     CrossRef
• The relationship between sleep disturbance and glycaemic control in adults with type 2 diabetes: An integrative review
  Bingqian Zhu, Patricia E Hershberger, Mary C Kapella, Cynthia Fritschi
  Journal of Clinical Nursing.2017; 26(23-24): 4053.     CrossRef
• Quality of sleep and risk for obstructive sleep apnoea in ambulant individuals with type 2 diabetes mellitus at a tertiary referral hospital in Kenya: a cross-sectional, comparative study
  Sairabanu Mohammed Rashid Sokwalla, Mark David Joshi, Erastus Olonde Amayo, Kirtida Acharya, Jared Ongechi Mecha, Kenneth Kipyegon Mutai
  BMC Endocrine Disorders.2017;[Epub]     CrossRef
• Subjective sleep impairment in adults with type 1 or type 2 diabetes: Results from Diabetes MILES—The Netherlands
  Giesje Nefs, Esther Donga, Eus van Someren, Mariska Bot, Jane Speight, François Pouwer
  Diabetes Research and Clinical Practice.2015; 109(3): 466.     CrossRef
• Sleeping well and on time—a prevention and prescription for diabetes?
  Krishna G. Seshadri
  International Journal of Diabetes in Developing Countries.2015; 35(1): 1.     CrossRef
• Sleep Optimization and Diabetes Control: A Review of the Literature
  Teresa Arora, Shahrad Taheri
  Diabetes Therapy.2015; 6(4): 425.     CrossRef
• Sleep quality and its impact on glycaemic control in patients with type 2 diabetes mellitus
  Bing-Qian Zhu, Xiao-Mei Li, Dan Wang, Xing-Feng Yu
  International Journal of Nursing Sciences.2014; 1(3): 260.     CrossRef
• Sleep Disturbances and Glucoregulation in Patients with Type 2 Diabetes
  Eun-Hee Cho, HeyJean Lee, Ohk Hyun Ryu, Moon Gi Choi, Sang-Wook Kim
  Journal of Korean Medical Science.2014; 29(2): 243.     CrossRef
• Disturbed Subjective Sleep in Chinese Females with Type 2 Diabetes on Insulin Therapy
  Yingxiang Song, Xiao Ye, Leqin Ye, Bijun Li, Lijun Wang, Yanyin Hua, Ramon Andrade de Mello
  PLoS ONE.2013; 8(1): e54951.     CrossRef
• The relationship between sleep condition and autonomic nervous function in women in their 70s with type 2 diabetes mellitus
  Miki Sato, Yuko Yasuhara, Tetsuya Tanioka, Yukie Iwasa, Masafumi Miyake, Haruo Kobayashi, Rozzano C. Locsin, Seizo Kinoshita, Masatoshi Masuda, Hiroshi Shimizu
  Health.2013; 05(11): 1875.     CrossRef
• Epidemiology of insomnia: A review of the Global and Indian scenario
  D Bhattacharya, M K Sen, J C Suri
  Indian Journal of Sleep Medicine.2013; 8(3): 100.     CrossRef
• Letter: Prevalence and Correlates of Disordered Sleep in Southeast Asian Indians with Type 2 Diabetes (Diabetes Metab J 2012;36:70-6)
  Tomoyuki Kawada
  Diabetes & Metabolism Journal.2012; 36(4): 314.     CrossRef

About this article

Rajendran A, Parthsarathy S, Tamilselvan B, Seshadri KG, Shuaib M. Prevalence and Correlates of Disordered Sleep in Southeast Asian Indians with Type 2 Diabetes. Diabetes Metab J. 2012;36(1):70-76.

Received: Jun 23, 2011; Accepted: Oct 10, 2011

DOI: https://doi.org/10.4093/dmj.2012.36.1.70.

Download citation ↓